
Aptose Biosciences Investor Relations Material
Latest events

EGM 2024
Aptose Biosciences

Q1 2025
8 May, 2025

Q4 2024
27 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Aptose Biosciences Inc
Access all reports
Aptose Biosciences Inc. is a clinical-stage biotechnology company focused on developing targeted therapies for hematologic malignancies, including leukemia, lymphoma, and myeloma. The company leverages innovative approaches in small-molecule drug design to address unmet medical needs in cancer treatment. The company is headquartered in Toronto, Canada, and its shares are listed on the NASDAQ.
Latest articles
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
Ticker symbol
APTO
Country
🇺🇸 United States